Dexcom’s biggest triumph and its biggest let down this quarter both involved the FDA. On the positive side, a verdict from a special FDA panel means Dexcom may soon be able to change its CGM’s ...
The Healthy @Reader's Digest on MSN
Nearly 640,000 Blood Sugar Devices Have Been Recalled at the Nation’s Highest Risk Level
It's an evolved (and less prickly way) to monitor blood glucose, but a well known brand's defect could result in serious consequences.
Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...
Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of unexpected sensor failures. This recall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results